• Mashup Score: 0

    Objective Concerns about the affordability of medications are common in systemic lupus erythematosus (SLE), but the relationship between medication cost concerns and health outcomes is poorly understood. We assessed the association of self-reported medication cost concerns and patient-reported outcomes (PROs) in a multiethnic SLE cohort. Methods The California Lupus Epidemiology Study is a cohort of individuals with physician-confirmed SLE. Medication cost concerns were defined as having difficulties affording SLE medications, skipping doses, delaying refills, requesting lower-cost alternatives, purchasing medications outside the United States, or applying for patient assistance programs. Linear regression and mixed effects models assessed the cross-sectional and longitudinal association of medication cost concerns and PROs, respectively, adjusting for age, sex, race and ethnicity, income, principal insurance, immunomodulatory medications, and organ damage. Results Of 334 participants,

    Tweet Tweets with this article
    • Research Article Medication Cost Concerns and Disparities in Patient-Reported Outcomes Among a Multiethnic Cohort of Patients With Systemic Lupus Erythematosus 📰 https://t.co/GlXr9kbHCe #drugcosts #healthcare #disparities #patients #lupus https://t.co/fj7X1LQyvk

  • Mashup Score: 0
    Wolters Kluwer Health - 1 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • #Cancer patients who receive prescriptions for biosimilars, generics, and clinically appropriate lower-cost drugs instead of established, costlier drugs can reduce the total cost of care by 5% or more and maintain quality of care: https://t.co/t3ljFVpfpa #drugcosts #healthcare https://t.co/IS8WBAXTfp

  • Mashup Score: 1
    Wolters Kluwer Health - 1 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • #Cancer patients who receive prescriptions for biosimilars, generics, and clinically appropriate lower-cost drugs instead of established, costlier drugs can reduce the total cost of care by 5% or more and maintain quality of care: https://t.co/t3ljFVpfpa #drugcosts #healthcare https://t.co/FKQFVDFKnb

  • Mashup Score: 0
    Wolters Kluwer Health - 1 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • #Cancer patients who receive prescriptions for biosimilars, generics, and clinically appropriate lower-cost drugs instead of established, costlier drugs can reduce the total cost of care by 5% or more and maintain quality of care: https://t.co/t3ljFV7E0A #drugcosts #healthcare https://t.co/lBa0peuQcy